Cognitive decline and mood disruption are displacing hot flashes as the most disruptive symptoms of menopause, according to Dr. Alyssa Dweck, Chief Medical Officer at Bonafide Health, who is making the case in a nationwide satellite media tour. The campaign signals a broader industry shift: functional and nutraceutical brands targeting women's hormonal health are pivoting messaging away from vasomotor relief toward neuro-cognitive and psychological endpoints.
The Symptom Shift
For years, product development in the menopause category centered on hot flash and night sweat relief — the vasomotor symptoms most associated with declining estrogen. But growing clinical evidence and patient-reported outcome data suggest anxiety, brain fog, and mood instability may affect quality of life more significantly, particularly for peri- and post-menopausal women in their peak earning and caregiving years. Dweck's media visibility reinforces what many formulators and marketers in the women's wellness space have tracked: the cognitive symptom burden is underserved relative to its prevalence, and consumers are actively seeking structure-function solutions that address it.
Formulation and Market Context
The menopause supplement market has expanded well beyond black cohosh and soy isoflavones. Branded ingredients targeting stress adaptation — including ashwagandha standardized extracts, magnesium glycinate, and phosphatidylserine — are increasingly positioned for the peri-menopausal consumer. The category intersects directly with the nootropics and adaptogen segments, and operators building women's health supplement lines are finding that brain fog and anxiety claims resonate more strongly with the 40–55 demographic than legacy thermal-relief positioning. Finished-formulation brands have taken note: clinical endpoints around cortisol modulation, working memory, and mood stability are appearing with greater frequency in product dossiers aimed at this cohort.
The broader women's wellness supplement category is one of the fastest-growing segments in the U.S. functional nutrition market, driven in part by increased consumer literacy and a growing willingness to discuss menopause openly — a cultural shift accelerated by clinician advocates like Dweck. For functional food and beverage developers, the moment presents a formulation and positioning opportunity: products that deliver on cognitive and mood support, backed by peer-reviewed evidence and transparent dosing, are well-positioned to capture the underserved peri-menopausal consumer. Brands that pair credentialed medical voices with clinically substantiated ingredients will hold a structural advantage as the category matures.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.